These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23763864)

  • 1. Influence of pneumococcal vaccines and respiratory syncytial virus on alveolar pneumonia, Israel.
    Weinberger DM; Givon-Lavi N; Shemer-Avni Y; Bar-Ziv J; Alonso WJ; Greenberg D; Dagan R
    Emerg Infect Dis; 2013 Jul; 19(7):1084-91. PubMed ID: 23763864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between respiratory syncytial virus activity and pneumococcal disease in infants: a time series analysis of US hospitalization data.
    Weinberger DM; Klugman KP; Steiner CA; Simonsen L; Viboud C
    PLoS Med; 2015 Jan; 12(1):e1001776. PubMed ID: 25562317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumococcal conjugate vaccines decrease community-acquired alveolar pneumonia with and without pleural effusion in children <60 months in Southern Israel, 2002-2016.
    Triadou D; Givon-Lavi N; Greenberg D; Ben-Shimol S
    Infect Dis (Lond); 2020 Mar; 52(3):186-195. PubMed ID: 31774020
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute lower respiratory infections in Indigenous infants in Australia's Northern Territory across three eras of pneumococcal conjugate vaccine use (2006-15): a population-based cohort study.
    Binks MJ; Beissbarth J; Oguoma VM; Pizzutto SJ; Leach AJ; Smith-Vaughan HC; McHugh L; Andrews RM; Webby R; Morris PS; Chang AB
    Lancet Child Adolesc Health; 2020 Jun; 4(6):425-434. PubMed ID: 32450122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial.
    Lucero MG; Nohynek H; Williams G; Tallo V; Simões EA; Lupisan S; Sanvictores D; Forsyth S; Puumalainen T; Ugpo J; Lechago M; de Campo M; Abucejo-Ladesma E; Sombrero L; Nissinen A; Soininen A; Ruutu P; Riley I; Mäkelä HP
    Pediatr Infect Dis J; 2009 Jun; 28(6):455-62. PubMed ID: 19483514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seasonality of both bacteremic and nonbacteremic pneumonia coincides with viral lower respiratory tract infections in early childhood, in contrast to nonpneumonia invasive pneumococcal disease, in the pre-pneumococcal conjugate vaccine era.
    Ben-Shimol S; Greenberg D; Hazan G; Shemer-Avni Y; Givon-Lavi N; Dagan R
    Clin Infect Dis; 2015 May; 60(9):1384-7. PubMed ID: 25595749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Chest Radiography Examination as a Probe for Pneumococcal Conjugate Vaccine Impact on Lower Respiratory Tract Infections in Young Children.
    Ben-Shimol S; Dagan R; Givon-Lavi N; Avital D; Bar-Ziv J; Greenberg D
    Clin Infect Dis; 2020 Jun; 71(1):177-187. PubMed ID: 31414125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of PCV7/PCV13 introduction on community-acquired alveolar pneumonia in children <5 years.
    Greenberg D; Givon-Lavi N; Ben-Shimol S; Ziv JB; Dagan R
    Vaccine; 2015 Aug; 33(36):4623-9. PubMed ID: 26116251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of the pneumococcal conjugate vaccines on the incidence of community-acquired alveolar pneumonia in premature compared with in term-born infants.
    Faingelernt Y; Dagan R; Givon-Lavi N; van der Beek BA; Ben-Shimol S; Shany E; Greenberg D
    Vaccine; 2022 Jan; 40(4):568-573. PubMed ID: 34973848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality associated with seasonal and pandemic influenza and respiratory syncytial virus among children <5 years of age in a high HIV prevalence setting--South Africa, 1998-2009.
    Tempia S; Walaza S; Viboud C; Cohen AL; Madhi SA; Venter M; McAnerney JM; Cohen C
    Clin Infect Dis; 2014 May; 58(9):1241-9. PubMed ID: 24567249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumococcal conjugate vaccines in the prevention of childhood pneumonia.
    Ivády B
    Acta Microbiol Immunol Hung; 2010 Mar; 57(1):1-13. PubMed ID: 20350875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indirect Effects of 10-Valent Pneumococcal Conjugate Vaccine Against Adult Pneumococcal Pneumonia in Rural Western Kenya.
    Bigogo GM; Audi A; Auko J; Aol GO; Ochieng BJ; Odiembo H; Odoyo A; Widdowson MA; Onyango C; Borgdorff MW; Feikin DR; Carvalho MDG; Whitney CG; Verani JR
    Clin Infect Dis; 2019 Nov; 69(12):2177-2184. PubMed ID: 30785189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumococcal pneumonia and influenza: a deadly combination.
    Klugman KP; Chien YW; Madhi SA
    Vaccine; 2009 Aug; 27 Suppl 3():C9-C14. PubMed ID: 19683658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of pneumococcal conjugate vaccine 13 introduction on severe lower respiratory tract infections associated with respiratory syncytial virus or influenza virus in hospitalized children in Ulaanbaatar, Mongolia.
    Do LAH; Tsedenbal N; Khishigmunkh C; Tserendulam B; Altanbumba L; Luvsantseren D; Ulziibayar M; Suuri B; Narangerel D; Tsolmon B; Demberelsuren S; Nguyen C; Mungun T; von Mollendorf C; Badarch D; Mulholland K
    IJID Reg; 2024 Jun; 11():100357. PubMed ID: 38577554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential impact of pneumococcal conjugate vaccines on bacteremic pneumonia versus other invasive pneumococcal disease.
    Ben-Shimol S; Greenberg D; Hazan G; Givon-Lavi N; Gottesman G; Grisaru-Soen G; Dagan R;
    Pediatr Infect Dis J; 2015 Apr; 34(4):409-16. PubMed ID: 25764098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of pneumococcal conjugate vaccine against hospital admissions for pneumonia in Australian children: a retrospective, population-based, record-linked cohort study.
    Fathima P; Gidding HF; McIntyre PB; Snelling TL; McCallum L; de Klerk N; Blyth CC; Liu B; Moore HC
    Lancet Child Adolesc Health; 2019 Oct; 3(10):713-724. PubMed ID: 31439496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of 13-valent pneumococcal conjugate vaccination on virus-associated community-acquired pneumonia in elderly: Exploratory analysis of the CAPiTA trial.
    Huijts SM; Coenjaerts FEJ; Bolkenbaas M; van Werkhoven CH; Grobbee DE; Bonten MJM;
    Clin Microbiol Infect; 2018 Jul; 24(7):764-770. PubMed ID: 29050992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasopharyngeal Pneumococcal Carriage During Childhood Community-Acquired Alveolar Pneumonia: Relationship Between Specific Serotypes and Coinfecting Viruses.
    Greenberg D; Givon-Lavi N; Faingelernt Y; Ben-Shimol S; Avni YS; Bar-Ziv J; Dagan R
    J Infect Dis; 2017 Apr; 215(7):1111-1116. PubMed ID: 28011920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of pneumococcal conjugate vaccine on pneumonia hospitalization and mortality in children and elderly in Ecuador: Time series analyses.
    Jimbo Sotomayor R; Toscano CM; Sánchez Choez X; Vilema Ortíz M; Rivas Condo J; Ghisays G; Haneuse S; Weinberger DM; McGee G; de Oliveira LH
    Vaccine; 2020 Oct; 38(45):7033-7039. PubMed ID: 32981782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prospective, Population-based Study to Determine the Incidence and Bacteriology of Bacterial Conjunctivitis in Children <2 Years of Age Following 7-Valent and 13-Valent Pneumococcal Conjugate Vaccine Sequential Implementation.
    Dagan R; Ben-Shimol S; Greenberg D; Givon-Lavi N
    Clin Infect Dis; 2021 Apr; 72(7):1200-1207. PubMed ID: 32140705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.